Health status of users of hormone replacement therapy by hysterectomy status in Western Australia

Journal of Epidemiology and Community Health

Volumn 57, Issue 4, 2003, Pages 294-300

  Lambert, L J ^a   Straton, J A Y ^a   Knuiman, M W ^a   Bartholomew, H C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; TRIACYLGLYCEROL;

WOMENS HEALTH;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OCCUPATION; PREVALENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; AGED; CHOLESTEROL; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; HYSTERECTOMY; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TRIGLYCERIDES; WESTERN AUSTRALIA;

EID: 0242584986     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.57.4.294     Document Type: Article

References (45)

1. Stampfer M, Colditz G. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
2. Grodstein F, Stampfer M, Manson J, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
3. Grodstein F. Can selection bias explain the cardiovascular benefits of estrogen replacement therapy. Am J Epidemiol 1996;143:979-82.
4. Wilson P, Garrison R, Castelli W. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med 1985;313:1038-43.
5. Matthews KA, Kuller LH, Wing RR, et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-8.
6. Vandenbroucke J. How much of the cardioprotective effect of postmenopausal estrogens is real? Epidemiology 1995;6:207-8.
7. Matthews KA, Kuller LH, Wing RR, et al. Health prior to hormone use Am J Epidemiol 1996;143:983-4.
8. Posthuma W, Westendorp R, Vandenbrouche J. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ 1994;308:1268-9.
9. Herrington D, Reboussin D, Brosnihan K, et al. Effects of estrogen replacement on the progression of coronary-artery atheroscerosis. N Engl J Med 2000;343:522-9.
10. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
11. Speroff L. Postmenopausal hormone therapy and coronary heart disease:clinical implications of recent randomized trial results. Maturitas 2000;35:91-7.
12. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
13. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
14. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA 2002;288:366-8.
15. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.
16. Isaacs A, Britton A, McPherson K. Why do women doctors in the UK take hormone replacement therapy? J Epidemiol Community Health 1997;51:373-7.
17. Chiaffarino F, Parazzini F, Vecchia CL, et al. Correlates of hormone replacement therapy use in Italian women, 1992-1996. Maturitas 1999;33:107-15.
18. MacLennan A. Changes in the use of hormone replacement therapy in South Australia. Med J Aust 1995;162:420-2.
19. Shelley JM, Smith AMA, Dudley E, et al. Use of hormone replacement therapy by Melbourne women. Aust J Public Health 1995;19:387-92.
20. MacLennan AH, MacLennan A, Wilson D. The prevalence of hysterectomy in South Australia. Med J Aust 1993;158:807-9.
21. Wolf P, Madans J, Finucane F, et al. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol 1991;164:489-94.
22. Luoto R, Kaprio J, Reunanen A, et al. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol 1995;85:515-22.
23. Gordon T, Kannel W, Hjortland M, et al. Menopause and coronary heart disease. The Framingham Study. N Engl J Med 1978;313:1038-43.
24. Rosenberg L, Hennekens C, Rosner B, et al. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981;139:47-51.
25. Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. BMJ 1992;305:1403-8.
26. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94-100.
27. Ranney B, Abu-Ghazaleh S. The future function and forture of ovarian tissue which is retained in vivo during hysterectomy. Am J Obstet Gynecol 1977;128:626-34.
28. Beavis E, Brown J, Smith M. Ovarian function after hysterectomy with conservation of the ovaries in pre-menopausal women. J Obstet Gynaecol Br Comm 1969;76:969-78.
29. Scientific Group of the WHO. Research on the menopause in the 1990's. Geneva: World Health Organisation, 1996.
30. Mosca L, Grundy S, Judelson D, et al. Guide to preventive cardiology for women. J Am Coll Cardiol 1999;33:1751-5.
31. Rosano GM, Graziottin A, Fini M. Cardioprotective effects of ovarian hormones and the HERS in perspective. Maturitas 2000;34:S3-10.
32. Knuiman M, Jamrozik K, Welborn T, et al. Age and secular trends in risk factors for cardiovascular disease in Busselton. Aust J Public Health 1995;19:375-82.
33. Broadhurst R, Lambert L, Jamrozik K, et al. Hysterectomy: the major cause of premature menopause? Auckland, New Zealand: Australasian Menopause Society Annual Congress 1998.
34. Moorheod T, Hannaford P, Warskyj M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997;104:290-7.
35. Lancaster T, Surman G, Lawrence M, et al. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Community Health 1995;49:389-94.
36. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993;46:211-19.
37. Johannes CB, Crawford SL, Posner JG, et al. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-52.
38. Egeland GM, Matthews K, Kuller L, et al. Characteristics of noncontraceptive hormone users. Prev Med 1988;17:403-11.
39. Matthews KA, Kelsey SF, Meilahn EN, et al. Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women. Am J Epidemiol 1989;129:1132-44.
40. Darrow S, Russell M, Cooper M. Sociodemographic correlates of alcohol consumption among African-American and white women. Womens Health 1992;18:35-51.
41. Walsh B, Sacks F. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest 1993;91:2126-32.
42. Sacks F, Walsh B. Sex hormones and lipoprotein metabolism. Curr Opin Lipidol 1994;5:236-40.
43. Dallongeville J, Marecaux N, Isorez D, et al. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995;118:123-33.
44. Amigoni S, Morelli P, Parazzini F, et al. Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 1999;34:25-32.
45. Derby C, Hume AL, McPhillips J, et al. Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. Am J Obstet Gynecol 1995;173:544-50.